Encompass Health (EHC) Cash from Financing Activities (2009 - 2026)

Encompass Health has reported Cash from Financing Activities for 18 years, with the latest figure at -$102.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 21.4% year-over-year to -$102.5 million; the trailing twelve-month figure through Mar 2026 stood at -$403.3 million (up 4.07% YoY), and the FY2025 full-year result was -$431.2 million, down 30.43% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$102.5 million, down from -$97.4 million in the prior quarter.
• The five-year high for Cash from Financing Activities was -$16.5 million in Q4 2022, with the low at -$150.9 million in Q4 2024.
• Historically, Cash from Financing Activities has averaged -$71.0 million across 5 years, with a median of -$60.9 million in 2022.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 89.65% — and 2024, when it tumbled 404.68%.
• Encompass Health's Cash from Financing Activities stood at -$16.5 million in 2022, then tumbled by 81.21% to -$29.9 million in 2023, then plunged by 404.68% to -$150.9 million in 2024, then jumped by 35.45% to -$97.4 million in 2025, then slipped by 5.24% to -$102.5 million in 2026.
• The last three Cash from Financing Activities figures came in at -$102.5 million (Q1 2026), -$97.4 million (Q4 2025), and -$113.2 million (Q3 2025), per Business Quant data.